StonvexLoading…
StonvexStonvexStonvexCore line items from DKNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.05B | $4.77B | $3.67B | $2.24B |
Operating Income | $-15.82M | $-609.00M | $-789.23M | $-1.51B |
Net Income | $3.71M | $-507.29M | $-802.14M | $-1.38B |
EPS (Diluted) | $-0.01 | $-1.05 | $-1.73 | $-3.16 |
Total Assets | $4.53B | $4.28B | $3.94B | $4.04B |
Total Liabilities | $3.90B | $3.27B | $3.10B | $2.72B |
Cash & Equivalents | $1.13B | $788.29M | $1.27B | $1.31B |
Free Cash Flow OCF − CapEx | $647.50M | $407.59M | $-22.65M | $-657.92M |
Shares Outstanding | 495.90M | 481.95M | 462.60M | 436.51M |